Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Progesterone

No authors listed
In: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006.
.
Free Books & Documents
Review

Progesterone

No authors listed.
Free Books & Documents

Excerpt

Because of the low reported levels of progesterone in breastmilk, even with the high-dose products, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. The progesterone vaginal ring available outside the US produces maternal blood levels that are lower than those of ovulating women. Expert opinion holds that the risks of progestin-only contraceptive products usually are acceptable for nursing mothers at any time postpartum.[1,2]

In Russia, a progesterone gel (Progestogel, Besins Healthcare; not available in the US) has been used topically as a one-time application to the breasts to treat postpartum breast engorgement when more conservative measures have failed.[3] A subsequent study failed to detect any decrease in breast hardness 20 minutes after application of progesterone gel in mothers with engorgement.[4] The safety and efficacy of this use have not been well studied and the manufacturer of Progestogel recommends avoiding its use during lactation.

PubMed Disclaimer

References

    1. World Health Organization. Medical Eligibility Criteria For Contraceptive Use: Sixth Ed. 2025. https://www.who.int/publications/i/item/9789240115583 - PubMed
    1. Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep 2024;73:1–126. - PMC - PubMed
    1. Pustotina O. Management of mastitis and breast engorgement in breastfeeding women. J Matern Fetal Neonatal Med 2016;29:3121–5. - PubMed
    1. Alekseev NP. Progesterone-containing gel does not eliminate postpartum breast engorgement? Breastfeed Med 2017;12:122–3. - PubMed
    1. Croxatto HB, Díaz S. The place of progesterone in human contraception. J Steroid Biochem 1987;27:991–4. - PubMed

LinkOut - more resources